Understanding How Treatments Get Approved - What It Means for You
About this episode
Dr. Z and Dr. C interview Dr. Sarah Gheuens to explain FDA approval processes and their significance for patients.
Dr. Z and Dr. C sit down with Dr. Sarah Gheuens, Chief Medical Officer and Head of R&D at Agios Pharmaceuticals, to break down one of the most frequently heard but least understood terms in the treatment conversation: FDA approval. From the phases of clinical development and the role of regulators, to the difference between traditional and accelerated approval pathways, Dr. Gheuens demystifies the science and the process in plain language. They also discuss why asking questions of physicians about their care is one of the most important things a patient can do. SHOW DESCRIPTION Cheat Codes is intended for patients, caregivers, providers, and the greater community of people who are impacted by Sickle Cell Disease. Each episode, Cheat Codes strives to provide listeners with critical education, the latest scientific updates, and voices from the Sickle Cell community. Join an inclusive community and build connections with other hemolytic anemia allies by following @AllyVoicesRising on Instagram. TRANSPARENCY STATEMENT Cheat Codes: A Sickle Cell Podcast is made possible by Agios Pharmaceuticals Inc. Visit Agios.com to learn more. The following Agios-supported programs are intended…
Sponsors
Agios Pharmaceuticals Inc.
More episodes of Cheat Codes: A Sickle Cell Podcast
Explore listener stats, chart rankings, contacts and more on the Cheat Codes: A Sickle Cell Podcast podcast page.